PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AMGN vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMGN and ABBV is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

AMGN vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amgen Inc. (AMGN) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

300.00%400.00%500.00%600.00%700.00%800.00%JulyAugustSeptemberOctoberNovemberDecember
307.91%
711.84%
AMGN
ABBV

Key characteristics

Sharpe Ratio

AMGN:

-0.05

ABBV:

0.84

Sortino Ratio

AMGN:

0.11

ABBV:

1.16

Omega Ratio

AMGN:

1.01

ABBV:

1.19

Calmar Ratio

AMGN:

-0.06

ABBV:

1.05

Martin Ratio

AMGN:

-0.15

ABBV:

2.88

Ulcer Index

AMGN:

9.40%

ABBV:

6.95%

Daily Std Dev

AMGN:

25.85%

ABBV:

23.75%

Max Drawdown

AMGN:

-78.04%

ABBV:

-45.09%

Current Drawdown

AMGN:

-21.31%

ABBV:

-13.88%

Fundamentals

Market Cap

AMGN:

$142.96B

ABBV:

$309.92B

EPS

AMGN:

$7.82

ABBV:

$2.88

PE Ratio

AMGN:

34.01

ABBV:

60.90

PEG Ratio

AMGN:

1.91

ABBV:

0.42

Total Revenue (TTM)

AMGN:

$32.43B

ABBV:

$55.53B

Gross Profit (TTM)

AMGN:

$19.57B

ABBV:

$42.68B

EBITDA (TTM)

AMGN:

$13.05B

ABBV:

$24.24B

Returns By Period

In the year-to-date period, AMGN achieves a -5.79% return, which is significantly lower than ABBV's 17.45% return. Over the past 10 years, AMGN has underperformed ABBV with an annualized return of 8.34%, while ABBV has yielded a comparatively higher 15.26% annualized return.


AMGN

YTD

-5.79%

1M

-8.51%

6M

-13.25%

1Y

-2.86%

5Y*

4.78%

10Y*

8.34%

ABBV

YTD

17.45%

1M

4.66%

6M

4.83%

1Y

19.28%

5Y*

19.53%

10Y*

15.26%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMGN vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AMGN, currently valued at -0.05, compared to the broader market-4.00-2.000.002.00-0.050.84
The chart of Sortino ratio for AMGN, currently valued at 0.11, compared to the broader market-4.00-2.000.002.004.000.111.16
The chart of Omega ratio for AMGN, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.19
The chart of Calmar ratio for AMGN, currently valued at -0.06, compared to the broader market0.002.004.006.00-0.061.05
The chart of Martin ratio for AMGN, currently valued at -0.15, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.152.88
AMGN
ABBV

The current AMGN Sharpe Ratio is -0.05, which is lower than the ABBV Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of AMGN and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50JulyAugustSeptemberOctoberNovemberDecember
-0.05
0.84
AMGN
ABBV

Dividends

AMGN vs. ABBV - Dividend Comparison

AMGN's dividend yield for the trailing twelve months is around 3.42%, less than ABBV's 3.53% yield.


TTM20232022202120202019201820172016201520142013
AMGN
Amgen Inc.
3.42%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%1.53%1.65%
ABBV
AbbVie Inc.
3.53%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%3.03%

Drawdowns

AMGN vs. ABBV - Drawdown Comparison

The maximum AMGN drawdown since its inception was -78.04%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for AMGN and ABBV. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-21.31%
-13.88%
AMGN
ABBV

Volatility

AMGN vs. ABBV - Volatility Comparison

Amgen Inc. (AMGN) and AbbVie Inc. (ABBV) have volatilities of 7.02% and 6.74%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember
7.02%
6.74%
AMGN
ABBV

Financials

AMGN vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Amgen Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab